Searching map area
Giovanni Martinelli
? TBD
hematologist
Join to rate
Ratings
0
Nobody has rated this yet. Be the first!
Works
7
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia
article by Simona Soverini et al published 15 December 2006 in Clinical Cancer Research
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party
article by Gabriele Gugliotta et al published 26 May 2011 in Blood
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis
scientific article
Farnesyltransferase inhibition in hematologic malignancies: the clinical experience with tipifarnib.
scientific article published on April 2008
Nilotinib against high dose imatinib for salvage therapy of chronic myeloid leukaemia
article
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party o
article by Simona Soverini et al published 20 June 2005 in Journal of Clinical Oncology
Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.
scientific article published in February 2004
Lists
0
Join to rate
Instance of
Human
Wikidata